Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. (Q50129587)

25 February 2018

title

Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. (English)

1 reference

25 February 2018

1 reference

1 reference

4

Charles N Serhan

1 reference

25 February 2018

author name string

James A Hamilton

1

1 reference

25 February 2018

Hatice Hasturk

2

1 reference

25 February 2018

Alpdogan Kantarci

3

1 reference

25 February 2018

Thomas Van Dyke

5

1 reference

25 February 2018

publication date

6 November 2017

1 reference

25 February 2018

Current Atherosclerosis Reports

published in

1 reference

25 February 2018

volume

19

1 reference

25 February 2018

page(s)

57

1 reference

25 February 2018

issue

12

1 reference

25 February 2018

https://scigraph.springernature.com/pub.10.1007/s11883-017-0696-4

exact match

0 references

cites work

Inflammation and plaque vulnerability

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Atherosclerosis and thrombosis: insights from large animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Mechanisms of plaque vulnerability and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Pathology of arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Images in cardiovascular medicine. Healing of an asymptomatic carotid plaque ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

A prospective natural-history study of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Prevalence of periodontitis in adults in the United States: 2009 and 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Role for Periodontitis in the Progression of Lipid Deposition in an Animal Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Antibodies to periodontal pathogens are associated with coronary plaque remodeling but not with vulnerability or burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

"Gum bug, leave my heart alone!"--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Periodontitis: from microbial immune subversion to systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Specialized pro-resolving mediators in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

The role of omega-3 derived resolvins in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolution of acute inflammation in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Pro-resolving lipid mediators are leads for resolution physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E2 formation and impact in inflammation resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 receptor activation signals phosphorylation and phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolution of inflammation: the beginning programs the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1 protects the rat heart against reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Infection regulates pro-resolving mediators that lower antibiotic requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Animal models of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

A robust rabbit model of human atherosclerosis and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Screening for sudden cardiac death in the young: report from a national heart, lung, and blood institute working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Relationship between the population incidence of febrile convulsions in young children in Sydney, Australia and seasonal epidemics of influenza and respiratory syncytial virus, 2003-2010: a time series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Intraplaque and Cellular Distribution of Dextran-Coated Iron Oxide Fluorescently Labeled Nanoparticles: Insights Into Atherothrombosis and Plaque Rupture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Frequency of sudden cardiac death and profiles of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

M1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Immune-inflammatory Activation in Acute Coronary Syndromes: A Look into the Heart of Unstable Coronary Plaque.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Statin use is associated with fewer periodontal lesions: A retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Heterogeneity of Coronary Plaque Morphology and Natural History: Current Understanding and Clinical Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Platelets: Context-Dependent Vascular Protectors or Mediators of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Macrophage death and defective inflammation resolution in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-017-0696-4

Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research

21 January 2018

1 reference

12 December 2020

Rabbit arterial thrombosis production by systemic procedures

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions

1 reference

12 December 2020

[Effects of vascular catheterization in normo- and hypercholesteremic rabbits]

1 reference

12 December 2020

Pathology of the vulnerable plaque

1 reference

12 December 2020

Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis

1 reference

12 December 2020

Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice

1 reference

12 December 2020

Large hemangiopericytoma associated with arteriovenous malformations and dural arteriovenous fistulae

1 reference

12 December 2020

[The discovery of blood circulation: revolution or revision?].

1 reference

12 December 2020

Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study

1 reference

12 December 2020

10.1007/S11883-017-0696-4

Identifiers

DOI

1 reference

25 February 2018

PubMed ID

29110146

1 reference

25 February 2018